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Abstract 
Background: Nutrition of the newborn during the early postnatal period seems to be of capital importance and 
there is clinical evidence showing the protective effect of breastfeeding compared with formula feeding on child‑
hood obesity and its comorbidities. Infants born small for gestation age may be more sensitive to the type of feed‑
ing during lactation. Here, we aimed to analyze the impact of birth weight and the type of infant feeding on the 
expression levels in peripheral blood cells of selected candidate genes involved in energy homeostasis in 5‑year‑old 
children, to find out potential early biomarkers of metabolic programming effects during this period of metabolic 
plasticity.
Methods: Forty subjects were recruited at birth and divided in four groups according to birth weight (adequate or 
small for gestational age) and type of infant feeding (breastfeeding or formula feeding). They were followed from birth 
to the age of 5 years.
Results: At 5 years, no significant differences regarding anthropometric parameters were found between groups, 
and all children had normal biochemical values. Expression levels of UCP2 and MC4R in peripheral blood cells 
were lower and higher, respectively, in formula feeding children compared with breastfeeding ones (P = 0.002 and 
P = 0.064, two‑way ANOVA). Differences were more marked and significant by Student’s t test in small for gestation 
age children (P < 0.001 and P = 0.017, respectively). Transcript levels of FASN and FTO in peripheral blood cells were 
also different according to the type of infant feeding, but only in small for gestation age children.
Conclusions: Altogether, these results suggest that small for gestation age infants are more sensitive to the type of 
feeding during lactation, and transcript levels of particular genes in peripheral blood cells, especially the MC4R/UCP2 
mRNA ratio, may precisely reflect these effects in the absence of clear differences in phenotypic traits.
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Background
Intrauterine and early life events are thought to be very 
important in the development of chronic disorders, con-
tributing to the developmental origins of cardiometabolic 
disease mainly in adults [1]. Much evidence supports the 
fact that low birth weight children have an increased risk 
to develop cardiovascular illnesses compared with nor-
mal weight ones [2]. Poor growth in utero contributes 
to insulin resistance, significant increased risk for type 
2 diabetes mellitus, obesity, hypertension, dyslipidemia, 
and coronary heart disease [2, 3]. The time immediately 
before and after birth may be a sensitive period related to 
programming cardiometabolic risk [4]. Therefore, a criti-
cal window of opportunity to modify programming may 
exist during pregnancy and throughout the first years 
of life. Conditions or dietary interventions during the 
lactation period may even potentially reverse metabolic 
malprogramming due to adverse in utero conditions, as 
demonstrated in animal models of maternal undernutri-
tion [5, 6].
In this regard, nutrition of the newborn during the 
early postnatal period seems to be of capital importance 
[7]. Different lines of clinical evidence show the protec-
tive effect of breastfeeding against childhood obesity and 
its comorbidities [8, 9]. Several theories have been pro-
posed to explain this protective effect, including behavio-
ral and nutritional explanations [10], such as differences 
in milk energy density and macronutrient composition 
[11], the impact of breastfeeding on microbiota com-
position [12], or the implication of specific bioactive 
compounds [13], particularly those that occur naturally 
in human breast milk and are absent in infant formula, 
such as leptin [14–17]. It is likely that beneficial effects of 
breastfeeding are particularly relevant in low birth weight 
infants [18].
To be able to predict the increased risk of metabolic-
syndrome related alterations due to early programming 
events is a challenge. This may allow the application of 
strategies at a time when there are more opportunities to 
prevent the increased risk, and before phenotypic altera-
tions become evident. Thus, it must be helpful to have 
reliable, early biomarkers of increased propensity to these 
alterations and sensitive to nutritional interventions at 
early life.
Peripheral blood cells, considering whole peripheral 
blood (PBC) or a subpopulation of white blood cells com-
posed basically by lymphocytes and monocytes, the so-
called peripheral blood mononuclear cells (PBMC), are 
easily accessible from blood samples, and they have been 
proposed as a useful source of markers to potentially 
predict some aspects of the pathological and physiologi-
cal state of the organism [19, 20]. We have previously 
described the presence of low expression levels of energy 
metabolism-related genes, such as INSR, CPT1A and 
FASN, in PBC of obese children with high plasma triglyc-
eride levels, whereas children with high expression levels 
displayed plasma levels of TG similar to normal-weight 
children [21]. In the case of CPT1A, low expression lev-
els were also related to higher HOMA index in obese 
children [21]. Therefore, expression levels of these genes 
were proposed as potential biomarkers of the metabolic 
status of obese children as they are indicative of the risk 
for the insulin-resistant or dyslipidemic state associated 
with obesity. Moreover, in a previous study we also found 
a relationship between breastfeeding and an increased 
expression of some of these protective biomarkers; 
breastfed children displayed higher expression levels of 
INSR and FASN in PBC compared with formula-fed sub-
jects [22]. Determination of expression levels of these 
and other potential candidate genes related with energy 
homeostasis in children born with low or adequate 
weight may be of interest, particularly as they may reflect 
the beneficial effects of breastfeeding.
Therefore, the objective of the present study was to 
analyze the impact of birth weight and the type of feed-
ing during infancy (breastfeeding or formula feeding) on 
the expression levels in PBC of selected candidate genes 
involved in energy homeostasis (CPT1, FAS, FTO, INSR, 
LEPR, MC4R, and UCP2) in a subset of children followed 
from birth to the age of 5 years to find out potential bio-
markers of metabolic programming effects during this 
period of metabolic plasticity.
Methods
Participants
Subjects involved in this study were a subset of 40 
infants from the COMETA cohort and born in the Hos-
pital General Universitario de Valencia, Spain [23]. 
Subjects invited to participate were newborns born at 
term (gestational age ≥ 37  weeks) after uncomplicated 
pregnancies and in the absence of perinatal illness. 
Exclusion criteria were multiple gestations, cesarean 
section or plan to move out of the area after delivery. 
The subjects included in the present study (males and 
females) were randomly selected at birth, according to 
body weight (BW) for gestational age (appropriate or 
small) and the planned type of infant feeding (breast 
feeding or formula feeding). Gestational age at birth 
was ascertained according to the method of Ballard 
et  al. [24]. Infants that were below the 10th percen-
tile for gestational age and sex were considered small 
for gestational age (SGA), and those between the 10th 
and 90th percentile were considered appropriate for 
gestational age (AGA) [25]. The general characteris-
tics of gestation and delivery were obtained from rou-
tine obstetric records. The type of feeding was assessed 
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during the first year of life. Infants that were exclusively 
fed with formula were classified as formula-fed group 
(FF). Those that were breastfed for at least 3  months, 
even when combined with formula, were classified as 
breastfed (BF), as other studies have described signifi-
cant differences in the prevalence of obesity in children 
who were never breastfed compared with those ever 
breastfed, including short periods of breastfeeding [8, 
22, 26].
At birth, all parents gave permission for their children 
to participate in the study and informed consent was 
obtained. The Committee for the Protection of Human 
Subjects of the Hospital General approved the study 
according to the Second declaration of Helsinki (2013).
Anthropometric and biochemical measurements
At birth, nude body weight was obtained by using a Seca 
728 scale in duplicate with both measures having to be 
within 10 g; in the event they fell outside of these prede-
fined parameters, a third measure was obtained with the 
2 closest values averaged. Crown-to-heel length at birth 
was obtained by using a Seca 416 infantometer in dupli-
cate with both measures having to be within 0.1  cm; in 
the event they fell outside of these predefined param-
eters, a third measure was obtained with the 2 closest 
averaged values.
At 5  years, body weight was recorded to the nearest 
0.1 kg using a standard beam balance scale with the sub-
jects wearing light indoor clothing and no shoes. Height 
was recorded to the nearest 0.5 cm using a standardized 
wall-mounted height board. Body mass index (BMI) and 
the corresponding standard deviation (SD) were calcu-
lated, with BMI being the weight in kilograms divided by 
the square of the height in meters. BMI z score (BMIz) 
was calculated by expressing a child’s BMI relative to chil-
dren in the World Health Organization (WHO) growth 
charts on the basis of the previously described method 
[27]. Values of L (lambda), M (mu) and S (sigma) varied 
according to a child’s sex and age. Subjects with a BMI 
z score ranging from 1 to 2 were defined as being over-
weight. Obesity was defined as having a BMI +2SD value, 
following WHO recommendations [28].
At 5  years of age, a metabolic assessment was per-
formed under fasting conditions in the early morning. 
Peripheral blood samples were obtained to measure glu-
cose by the glucose oxidase method (Beckman Glucose 
Analyzer, Beckman Instruments, Fullerton, CA), insulin 
(Pharmacia Insulin RIA kit; Uppsala, Sweden), lipid pro-
file, and uric acid. The homeostatic model assessment 
(HOMA) index was calculated by dividing the product of 
insulin (microunits per milliliter) and glucose (millimoles 
per liter) by 22.5 [29].
Casual blood pressure measurements
At birth (on the second day of life) and at 5  years, 
blood pressure (BP) measurements were performed. 
Nurses measured the BP three consecutive times using 
a Dinamap (Pro Care, GE Medical Systems Informa-
tion Technologies, Inc, Milwaukee, WI) oscillometric 
recorder [30]. The mean of the three measurements was 
taken as the casual BP. For measurements made at birth, 
the subjects were in the supine position or in the care 
provider’s lap, in a state of quiet sleep or quiet waken-
ing. For measurements at 5  years, the child was seated. 
The appropriate cuff, placed on the left arm, was selected 
according to the length of the upper arm of each subject; 
the cuff extended completely around the arm and width 
of the bladder covered at least two-thirds of the upper 
arm [31].
Blood sampling and processing for gene expression 
analysis
At 5 years of age, a total of 2.5 ml peripheral blood was 
collected from each participant under fasting condi-
tions into PAX gene vacutainer tubes (QIAGEN, Hilden, 
Germany) via antecubital fossa venipuncture, following 
the manufacturer’s instructions (QIAGEN). This system 
allows collection and immediate stabilization of intracel-
lular RNA of total blood cells without further manipu-
lations, facilitating standardisation and reproducibility. 
This makes it an attractive approach in human studies 
[21].
Total RNA was isolated using the PAX gene blood 
RNA kit according to the manufacturer’s instructions 
(QIAGEN). RNA quality and purity were analysed by 
spectrophotometry using the Nanodrop ND-1000, 
and RNA integrity was confirmed using agarose gel 
electrophoresis.
Real‑time quantitative RT‑PCR analysis
Expression levels of selected genes were determined by 
quantitative RT-PCR analysis. Genes analysed were: car-
nitine palmitoyl transferase 1 alpha (CPT1A), fatty acid 
synthase (FASN), alpha-Ketoglutarate dependent dioxy-
genase (FTO), insulin receptor (INSR), leptin receptor, 
long-form (LEPR), melanocortin 4 receptor (MC4R), 
and uncoupling protein 2 (UCP2). Selection of genes was 
based both on previous studies showing changes in their 
expression levels in PBC of children according to type 
of infant feeding, body weight, and/or metabolic status 
(the most representative of them), and their relevance in 
energy homeostasis and obesity predisposition. Specifi-
cally, FASN, INSR and UCP2 were found to be differently 
expressed in PBC between breastfed and formula fed 
children [22]; expression levels of CPT1A, INSR, FASN, 
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LEPR were related to insulin-resistant or dyslipidemic 
state of children [21]; and expression levels of MC4R 
were described to be associated with BMI z-score, and 
body fat percentage [32]. FTO was also analysed because 
of the relevance of gene variants on obesity predisposi-
tion [33, 34]. All primers were obtained from Sigma 
Genosys (Sigma-Aldrich Quimica SA, Madrid, Spain).
Quantitative RT-PCR was performed as previously 
described [35]. The threshold cycle (Ct) was calculated 
using the instrument’s software (StepOne Software ver-
sion 2.0), and the relative expression ratio of a target gene 
was calculated based on the corresponding real-time 
PCR efficiency and Ct deviation of an unknown sample 
vs. mean Ct of all samples and expressed in comparison 
to a reference gene [36]. TRIM27 (Homo sapiens tripar-
tite motif containing 27) was chosen as reference gene 
because expression levels were stable across all groups. 
TRIM27 has been previously used as reference gene in 
PBC samples in children [37].
Statistical analysis
Data are expressed as mean ± SD. Differences among the 
groups of study were assessed using two-way ANOVA. 
Student’s t test was used to compare individual means.
Multiple linear regression analysis, using anthropomet-
ric, BP values and metabolic parameters as dependent 
variables and expression of the different genes, as inde-
pendent variables, was calculated.
Results
Characteristics of study subjects
Of the 50 subjects who accepted the invitation to partici-
pate in the present study, 10 did not have follow-up data. 
The remaining forty subjects (21 males and 19 females), 
who fulfilled the inclusion criteria and had their data 
recorded at follow up, were included in the study.
General characteristics of the sample, divided into four 
groups in terms of weight (AGA and SGA) and type of 
feeding at birth (BF and FF) are shown in Table  1. At 
birth, mean gestational age was 39.1 ± 1.4 weeks, and the 
average BW was 2909 ± 561 g. SGA infants had lower val-
ues of systolic BP than AGA children (P = 0.041, two-way 
ANOVA). At 5 years of age, 40% of all subjects were over-
weight or obese, but no significant differences were found 
in the distribution among groups (data not shown). The 
high prevalence of obesity in the study population could 
be seen as not representative of the general population. 
Nevertheless, the prevalence of overweight and obesity in 
the AGA group was similar to the average prevalence in 
Spanish children [38]. No significant differences regard-
ing anthropometric parameters and blood pressure val-
ues were found between groups.
At 5  years, all children had normal biochemical val-
ues for their age, and no significant differences between 
groups were found except for insulin and HOMA 
index, which were significantly lower in FF vs BF chil-
dren (P = 0.017 and P = 0.012, respectively; two-way 
ANOVA). An interactive effect was also found by two-
way ANOVA regarding uric acid and HDL-cholesterol 
between type of feeding and BW at birth (P = 0.028 and 
P = 0.006, respectively). Specifically, FF children of the 
SGA displayed higher uric acid levels than FF children of 
the AGA group (P = 0.048, Student’s t test); in addition, 
in the AGA group, uric acid levels were lower in FF sub-
jects compared with BF subjects (P = 0.027, Student’s t 
test). Regarding HDL-cholesterol, BF subjects of the SGA 
group displayed higher levels than BF subjects of the 
AGA group (P = 0.045, Student’s t test); in addition, FF 
subjects of the AGA group showed higher HDL-choles-
terol than BF subjects (P = 0.011, Student’s t test).
Gene expression levels in peripheral blood cells
Gene expression analysis in PBC was performed in chil-
dren at 5 years. Blood samples for gene expression were 
available from 38 children out of the 40 that participated 
in the study.
Results showing expression levels of selected genes in 
PBC at 5  years in AGA and SGA children, taking into 
account if they were breastfed or formula-fed, are shown 
in Fig. 1. Results showed that expression levels of UCP2 
were significantly lower in FF children compared with 
BF ones (P = 0.002, two-way ANOVA), and differences 
were more marked in SGA children (P < 0.001, Student’s 
t-test). Moreover, FF children of the SGA group displayed 
lower expression of UCP2 than those of the AGA group 
(P = 0.054, Student’s t-test).
An effect of the type of infant feeding was also found 
regarding MC4R. Expression levels were higher in FF 
subjects compared with BF ones, although differences 
did not reach statistical significance (P = 0.064, two-
way ANOVA). However, differences were more marked 
among SGA children, since those that were FF showed 
higher expression levels of MC4R than BF children 
(P = 0.017, Student’s t-test).
Concerning FASN and FTO transcripts, there was an 
interaction between type of infant feeding and BW at 
birth (P = 0.059 and P = 0.003, respectively, two-way 
ANOVA). Among SGA children, BF ones displayed 
higher expression levels of both genes than FF ones 
(P = 0.047 and P = 0.014, respectively, Student’s t-test). 
In addition, among BF children, those that were SGA dis-
played higher expression levels of both genes than those 
that showed AGA (P = 0.004 and P = 0.005, respectively, 
Student’s t-test).
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No significant differences were found regarding tran-
script levels of LEPR, INSR, or CPT1A concerning BW at 
birth or type of infant feeding.
Association of gene expression on anthropometric, blood 
pressure and biochemical parameters of subjects
The potential association between anthropometric, blood 
pressure and metabolic parameters at 5 years of age, and 
gene expression at this age was analysed using a multi-
ple regression analysis, which included each parameter 
as the dependent variable and gene expression as inde-
pendent variable (Table  2). No significant associations 
were found between gene expression and anthropometric 
measurements (data not shown). Nevertheless, in terms 
of blood pressure, systolic blood pressure (SBP) was neg-
atively associated with INSR expression levels (P = 0.018) 
(Table  2). Regarding metabolic parameters, uric acid 
levels were negatively associated with the expression 
levels of UCP2 (P = 0.031); HDL-cholesterol levels were 
negatively associated with expression levels of FASN 
(P = 0.022) and positively with expression levels of FTO 
(P = 0.007); and insulin levels were positively associated 
with expression levels of FASN (P = 0.011) (Table 2).
Discussion
The present prospective study performed in children 
born at term after a non-complicated pregnancy shows 
significant differences in transcript levels in PBC of genes 
related to different metabolic pathways at the age of 
5  years, according to birthweight and the type of infant 
feeding. Notably, expression levels were particularly dif-
ferent as an effect of the type of infant feeding in SGA 
children. These results are in agreement with the poten-
tial interest of gene expression levels in blood cells at 
Table 1 General characteristics of the sample grouped by birth weight and type of infant feeding
Results are mean ± standard deviation (SD). Statistical analysis: W: effect of birth weight; F: effect of the type of infant feeding; W*F: interactive effect between birth 
weight and type of infant feeding (P < 0.05, two‑way ANOVA). f represents differences between FF and BF within the same group of birth weight; w represents 
differences between AGA and SGA within the same group of infant feeding (P < 0.05, Student’s t test)
AGA, appropriate for gestational age; SGA, small for gestational age; BF, breastfed; FF, formula fed; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart 
rate; BMI, body mass index; HDL, high‑density lipoprotein; LDL, low‑density lipoprotein; HOMA, homeostasis model assessment; ns, not‑significant
Variable (mean ± SD) AGA (n = 21) SGA (n = 19) ANOVA
BF (n = 8) FF (n = 13) BF (n = 10) FF (n = 9)
Subjects (total%) 20.0 32.5 25.0 22.5
Sex m/f 5/3 8/5 3/7 5/4
At birth
 Weight (g) 3439 ± 236 3335 ± 330 2390 ± 248w 2401 ± 225w W (P < 0.001)
 Height (cm) 51.0 ± 2.5 50.0 ± 2.0 46.0 ± 1.2w 46.5 ± 2.2bw W (P < 0.001)
 SBP (mmHg) 78 ± 9 69 ± 8f 66 ± 10bw 68 ± 10 W (P = 0.041)
 DBP (mmHg) 45 ± 7 42 ± 9 40 ± 10 37 ± 8 ns
 HR (bpm) 124 ± 8 126 ± 19 122 ± 21 129 ± 14 ns
At 5 year old (mean age) 4.7 ± 0.7 5.2 ± 0.6 5.2 ± 0.9 5.1 ± 0.6 ns
 Weight (kg) 23.0 ± 6.2 21.3 ± 4.2 20.0 ± 3.4 20.2 ± 3.2 ns
 Height (cm) 112 ± 9 112 ± 6 110 ± 5 112 ± 5 ns
 BMI (kg/m2) 18.0 ± 2.3 16.9 ± 3.0 16.4 ± 2.2 15.9 ± 1.8 ns
 BMI percentile 86 ± 14 65 ± 35 64 ± 33w 58 ± 27 ns
 BMI‑Z score 1.59 ± 1.12 0.86 ± 1.86 0.65 ± 1.28w 0.36 ± 1.02 ns
 SBP (mmHg) 97 ± 5 91 ± 7 96 ± 7 95 ± 10 ns
 DBP (mmHg) 53 ± 5 54 ± 5 58 ± 4 56 ± 11 ns
 HR (bpm) 96 ± 6 88 ± 29 99 ± 13 95 ± 8 ns
 Glucose (mg/dL) 83 ± 5 81 ± 5 81 ± 6 76 ± 12 ns
 Uric acid (mg/dL) 4.05 ± 0.89 3.20 ± 0.67f 3.60 ± 0.57 3.90 ± 1.02w W*F (P = 0.028)
 Creatinine (mg/dL) 0.30 ± 0.40 0.33 ± 0.06 0.34 ± 0.08 0.33 ± 0.05 ns
 Triglycerides (mg/dL) 73 ± 18 59 ± 14 74 ± 47 60 ± 6 ns
 Total cholest. (mg/dL) 166 ± 28 174 ± 20 170 ± 33 162 ± 23 ns
 HDL cholest. (mg/dL) 46 ± 8 59 ± 11f 60 ± 16w 51 ± 9 W*F (P = 0.006)
 LDL cholest. (mg/dL) 106 ± 26 104 ± 20 96 ± 27 102 ± 18 ns
 Insulin (µIU/mL) 5.88 ± 1.68 4.24 ± 2.25 6.75 ± 3.71 4.06 ± 2.25 F (P = 0.017)
 HOMA‑index 1.21 ± 0.39 0.85 ± 0.47 1.31 ± 0.66 0.78 ± 0.44 F (P = 0.012)
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early ages as a marker of metabolic programming effects 
associated with birth weight and the type of infant feed-
ing, which may thereby predict the susceptibility to met-
abolic alterations in later life. In contrast, no relevant 
differences in body weight, metabolic profile or BP were 
found at 5  years of age, with the exception of uric acid, 
HDL-cholesterol and insulin levels. Nevertheless, in all 
cases, values of these parameters were in the normal 
range for age.
Regarding gene expression, one of the most signifi-
cant results of the present study is the different expres-
sion of UCP2 in PBC in terms of type of infant feeding. 
UCP2 was downregulated in FF children compared with 
BF ones, and the differences were more marked among 
the SGA subjects. Differences in UCP2 expression levels 
according to the type of infant feeding have been previ-
ously described in a group of 237 children aged 2–9 years 
from eight European countries [22]. We previously 
described that breastfed male subjects showed higher 
expression levels of this gene compared with formula-fed 
ones [22]. Notably, our present results, considering both 
male and female, confirm those findings. In addition, 
these results also show the importance of BF among chil-
dren in the SGA group, since it normalizes UCP2 expres-
sion levels to those of the AGA + BF group, which could 
be considered as the reference group in terms of future 
metabolic health.
UCP2 is involved in a broad range of pathological pro-
cesses. Remarkably, we have found an inverse association 
between UCP2 expression levels in PBC and uric acid 
levels. This relationship can be explained by the func-
tion of UCP2. This protein is present in the inner mito-
chondrial membrane and it mainly acts in the protection 
against oxidative stress, decreasing the ATP levels and 
reactive oxygen species (ROS) produced by electron 
transport [39]. Uric acid overproduction may occur as a 
result of the acceleration of ATP degradation to AMP, a 
precursor of uric acid [40] and UCP2 could decrease the 
ATP level and thereby reduce AMP levels for uric acid 
formation [41]. Therefore, although a cause-effect rela-
tionship cannot be established from our results, the pres-
ence of increased UCP2 expression levels as mirrored in 
PBC might reflect an increased potential to regulate ROS 
and the ATP/AMP ratio, and thereby a decreased risk 
of hyperuricemia and other related metabolic compli-
cations. The inverse association between UCP2 expres-
sion levels in PBC and uric acid levels is also of interest 
regarding the relevance of uric acid levels in relation to 
cardiometabolic risk factors, particularly high blood 
pressure and elevated insulin and triglycerides [42]. 
Lurbe et al. have previously described that uric acid levels 
in children at 5 and 10 years were significantly and inde-
pendently associated to birth weight [23, 43], and they 
were also positively correlated with blood pressure, insu-
lin and triglycerides in overweight and obese youths [42].
Other signs on the potential connection between 
UCP2 expression and uric acid levels have been previ-
ously suggested from studies in adult Chinese population 
Fig. 1 Gene expression data. Transcript levels in peripheral blood cells of CPT1A, FASN, FTO, INSR, LEPR, MC4R and UCP2 at 5 years in breastfed 
(BF) or formula‑fed (FF) children whose birth weight was appropriate or small for gestational age (AGA or SGA). Results are mean ± SD. Statistical 
analysis: F: effect of the type of infant feeding; W*F: interactive effects between birth weight and the type of infant feeding (P < 0.05, two‑way 
ANOVA). f represents differences between FF and BF within the same group of birth weight; w represents differences between AGA and SGA within 
the same group of infant feeding (P˂ 0.05, Student’s t test)
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showing a relation between the risk of hyperuricemia and 
genetic variants, such as the − 866G/A (rs659366) poly-
morphism located in the promoter region of UCP2 [41]. 
Females with the A allele, which is associated with higher 
UCP2 mRNA expression, had lower serum urate and 
a decreased risk of hyperuricemia, but no relation was 
found in males [41]. Therefore, the relationship between 
transcript levels of UCP2 in PBC and uric acid levels in 
blood merits further consideration in studies regarding 
early prevention of cardiometabolic risk factors.
MC4R has a well-established role in feeding behavior 
and energy homeostasis [44]. Transcript levels of MC4R 
were higher in FF children compared with BF children, 
particularly in SGA infants. It is noticeable that, as men-
tioned above for UCP2, breastfeeding normalized expres-
sion levels of MC4R in SGA children to the “reference” 
levels of the AGA + BF group. The meaning of differences 
in the expression levels of MC4R in PBC is not known, 
and, to our knowledge, this is the first study address-
ing MC4R expression levels in PBC in relation to birth 
weight and type of infant feeding. In a previous study, 
high expression levels of this gene in PBC were associ-
ated with the intake of high percentage of energy from 
fat, but also with lower body fat percentage and BMI 
z-score in children [45]. Here, although dietary intake 
was not assessed, no differences were found in terms of 
anthropometric parameters between BF and FF children 
of the SGA group, and no significant associations were 
found between expression levels of this gene and anthro-
pometric and biochemical measurements performed at 
5 years of age. However, the small sample size could be 
the reason for the lack of correlations. In any case, pre-
sent findings suggest that greater MC4R expression levels 
in PBC in children may be indicative of adverse program-
ming events during intrauterine life, while normaliza-
tion of transcript levels of this gene in children who were 
SGA may be indicative of adequate phenotypic repro-
gramming by adequate nutritional supply during lacta-
tion. Notably, considering the inverse trends between the 
expression levels of MC4R and UCP2 in SGA children 
according to the type of infant feeding, besides the poten-
tial interest of individual gene expression values by itself, 
the MC4R/UCP2 mRNA ratio could be of greater rele-
vance as a potential, more sensitive marker of the benefi-
cial effects of breast feeding in SGA infants.
Transcript levels of FASN in PBC have also been raised 
as potential biomarkers of metabolic alterations, particu-
larly related with lipid metabolism. Specifically, in chil-
dren, upregulation of FASN expression in PBC has been 
associated with lower triglyceride levels [21]. Moreover, 
FASN transcript levels in PBC have also been reported 
to be higher in children who were BF compared with FF 
ones [22]. Here, no relationship has been found between 
expression levels of this gene and triglyceride levels 
at 5  years of age (data not shown), which could be ten-
tatively attributed to the limited number of subjects. 
Although triglycerides were within the normal range 
and no differences were found between groups. Never-
theless, the presence of higher FASN expression levels 
Table 2 Association between  office systolic BP, metabolic 
parameters and  gene expression at  5  years of  age 
estimated by multiple regression analysis
Data with significant P value (< 0.05) are indicated in italic
CPT1A, carnitine palmitoyl transferase 1 alpha; FASN, fatty acid synthase; FTO, 
alpha‑Ketoglutarate dependent dioxygenase; INSR, insulin receptor; LEPR, Leptin 
receptor, long‑form; MC4R, Melanocortin 4 receptor, UCP2, Uncoupling protein 2
Variable Beta P value
Systolic blood pressure
 CPTL1 0.161 0.473
 FASN 0.133 0.578
 FTO 0.199 0.398
 INSR − 0.534 0.018
 LEPR − 0.128 0.578
 MC4R − 0.031 0.903
 UCP2 − 0.003 0.989
 R2: 0.279
Uric acid
 CPTL1 0.393 0.138
 FASN − 0.109 0.690
 FTO − 0.128 0.558
 INSR − 0.026 0.910
 LEPR − 0.096 0.692
 MC4R − 0.122 0.668
 UCP2 − 0.546 0.031
 R2: 0.38
HDL cholesterol
 CPTL1 0.409 0.071
 FASN − 0.534 0.022
 FTO 0.590 0.007
 INSR 0.126 0.525
 LEPR 0.152 0.476
 UCP2 0.121 0.559
 MC4R 0.176 0.474
 R2: 0.49
Insulin
 CPTL1 − 0.115 0.598
 FASN 0.672 0.011
 FTO − 0.170 0.451
 INSR − 0.414 0.062
 LEPR − 0.086 0.689
 MC4R 0.126 0.605
 UCP2 0.205 0.381
 R2: 0.337
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in BF compared with FF children, but only in SGA sub-
jects, is also described here, in agreement with previous 
results [22]. Notably, association studies have revealed 
that FASN expression levels in PBC are positively related 
with insulin levels at 5 years of age, which were found to 
be higher in BF compared with FF children and the dif-
ference was apparently greater in children that were 
SGA at birth. The biological meaning of this association 
could be interpreted according to the known function 
of insulin activating FASN expression [46], and the fact 
that PBC may reflect changes in gene expression occur-
ring in different tissues, such as liver, which has been 
described in animal models [20]. On the other hand, the 
negative association found between FASN expression lev-
els and HDL-cholesterol is more difficult to interpret, but 
it could be tentatively related with the essential role of 
insulin regulating HDL-cholesterol metabolism, since it 
favors HDL2 to HDL3 conversion, through its action on 
hepatic lipase [47]. However, in both cases, the possible 
clinical interest of these associations, if any, remains to be 
established.
A similar pattern to that of FASN has been observed 
regarding FTO expression. Breastfeeding was associ-
ated with FTO upregulation in PBC, but only in the SGA 
group. This fact also supports the hypothesis that the 
benefits of breastfeeding could be even more important 
in SGA subjects, and that such transcript-based biomark-
ers could reflect these early events more accurately than 
other clinical markers.
Despite the recognized relevance of FTO gene variants 
on obesity predisposition [33, 34] the relation between 
FTO expression in blood cells and biochemical or clini-
cal parameters related to metabolic syndrome is not 
well-defined. In adult humans, higher mRNA expression 
levels of FTO have been described to be greater in adi-
pose tissue of obese than normal weight individuals, but 
no differences have been found regarding FTO expres-
sion in peripheral blood mononuclear cells (PBMC) [48]. 
Here, we have found a positive correlation between FTO 
expression levels in PBC and HDL-cholesterol at 5 years 
of age. Evidence on the relationship between FTO and 
cardiovascular disease (CVD) exists from studies show-
ing the association of FTO gene variants with CVD risk, 
independently of BMI [49]. Some studies have described 
an association between the FTO gene rs9939609 poly-
morphism and HDL-cholesterol. Individuals carrying the 
risk allele, displayed decreased HDL-cholesterol concen-
tration [50]. Nevertheless, whether or not the association 
found in the present study involves causality remains to 
be ascertained.
Unlike the aforementioned genes, expression levels 
of other candidate genes studied in the present study, 
CPT1L, INSR and LEPR were not significantly different 
between groups. Results regarding CPT1L and LEPR 
agree with previous published results showing no signifi-
cant differences in their transcript levels in PBC between 
BF and FF children [22]. However, increased expression 
levels of INSR have been previously described in BF chil-
dren compared with FF children [22]. Here, no differ-
ences have been found in AGA children, but BF children 
from the SGA group showed a non-significant trend to 
higher INSR expression levels compared to FF children 
(P = 0.098). The limited sample size could be the reason 
for the lack of statistical significance. This is in accord-
ance with the general pattern described for other genes 
studied. Moreover, the finding of a negative correlation 
between transcript levels of INSR and SBP at 5  years 
of age may be considered in the light of the known link 
between insulin resistance and hypertension [51, 52]. 
In this regard, it is plausible to consider changes in the 
expression levels of INSR in PBC as an early molecular 
marker of future alterations frequently associated with 
hypertension.
The strengths and limitations of the present study 
must be taken into account. The study has a prospective 
design, with subjects recruited from birth, and includes 
data on pregnancy, birth, and early childhood growth, 
together with BP values and metabolic data, as well as 
data on gene expression analysis in blood cells. The study 
is focusing on an area with a lack of research: The rela-
tionship between BW and type of infant feeding, with 
gene expression in PBC as potential biomarkers of future 
metabolic status. However, one of the limitations of the 
study is the small sample size, which reduces statistical 
power. Another limitation may be the use of insulin levels 
and HOMA index as surrogate markers of insulin resist-
ance, which differs from the gold standard method, the 
hyperinsulinemic euglycemic clamp [53]. Nevertheless, 
the use of this method is mainly restricted to investiga-
tional facilities and is normally unavailable in the clinical 
setting.
Conclusions
In summary, present results show differences in gene 
expression in PBC in 5-year-old children due to the 
type of infant feeding, which, interestingly, are more 
marked in infants born SGA compared with those in 
the AGA group. This is particularly evident for MC4R 
and UCP2, whose expression levels were increased and 
decreased, respectively, in FF children and especially in 
SGA, which may be indicative of adverse programming 
during intrauterine life. Therefore, although it needs to 
be independently confirmed in future studies, increased 
MC4R/UCP2 mRNA ratio in PBC may be a hallmark 
of FF infants born SGA; whereas normalization of this 
ratio could be indicative of adequate reprogramming 
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by appropriate nutrition during lactation. Results also 
show differences in FASN and FTO expression lev-
els in PBC due to the type of infant feeding that were 
observed only in SGA children. The finding of a nega-
tive correlation between transcript levels of UCP2 and 
uric acid levels is also relevant, considering the relation 
of uric acid with cardiometabolic risk factors, such as 
blood pressure and circulating insulin and triglycerides 
[42]. Therefore, interventions to avoid the elevation of 
uric acid levels should be considered and breast feed-
ing might play an important role. Overall, these results 
suggest that SGA infants are more sensitive to the type 
of feeding during lactation and gene expression of par-
ticular genes in PBC may precisely reflect these effects 
in the absence of clear differences in phenotypic traits.
In terms of future work, it would be interesting to 
increase the sample size and power of analysis to be 
able to validate and make further correlations between 
gene expression and phenotypes and risk factors.
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